Synendos Therapeutics

Developer of endocannabinoid modulators for the treatment of CNS disorders

placeAllschwil, Basel Landschaft, Switzerland calendar_todayFounded 2019 groups9 employees language synendos.com

Registered entities

Social engagement

Social engagement: 4.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Ysios Capital, Kurma Partners, Sunstone.

Investor typeCountShare
Venture capital646%
Accelerator & incubator323%
Other / undisclosed431%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

17 Jun 2026 · Project Lead / Project Manager

Based on job postings tracked across public sources.

Recent activity

1 Jul 2026
Event
INTERNATIONAL CANNABINOID RESEARCH SOCIETY 2026
25 Jun 2026
Event
Presidential Plenary Lecture
18 Jun 2026
Event
INTERNATIONAL CANNABINOID RESEARCH SOCIETY conference
Coming soon